Swedish Orphan Biovitrum AB (CHIX:SOBIS) Cyclically Adjusted Book per Share: kr74.74 (As of Mar. 2026)


CHIX:SOBIS Swedish Orphan Biovitrum AB CHIX:SOBIS
85 GF Score
Price kr463.20
GF Value kr345.70
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share?

Swedish Orphan Biovitrum AB CHIX:SOBIS 85 Cyclically Adjusted Book per Share is kr74.74 as of Mar. 2026. GuruFocus rates CHIX:SOBIS with a GF Score™ of 85/100 and a GF Value™ of kr345.70 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Swedish Orphan Biovitrum AB's adjusted book value per share for the three months ended in Mar. 2026 was kr116.749. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr74.74 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Swedish Orphan Biovitrum AB's average Cyclically Adjusted Book Growth Rate was 13.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 17.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 21.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Swedish Orphan Biovitrum AB was 24.50% per year. The lowest was 13.00% per year. And the median was 19.55% per year.

As of today (2026-07-09), Swedish Orphan Biovitrum AB's current stock price is kr463.20. Swedish Orphan Biovitrum AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was kr74.74. Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio of today is 6.20.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Swedish Orphan Biovitrum AB was 13.83. The lowest was 3.88. And the median was 5.58.


Swedish Orphan Biovitrum AB  (CHIX:SOBIs) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=463.20/74.74
=6.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Swedish Orphan Biovitrum AB was 13.83. The lowest was 3.88. And the median was 5.58.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share Related Terms


Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Swedish Orphan Biovitrum AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share Chart

Swedish Orphan Biovitrum AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.77 48.13 49.64 65.11 70.15

Swedish Orphan Biovitrum AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.57 67.79 69.37 70.15 74.74

CHIX:SOBIS vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Swedish Orphan Biovitrum AB Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio falls into.


CHIX:SOBIS
85GF Score
Swedish Orphan Biovitrum AB CHIX:SOBIS
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Swedish Orphan Biovitrum AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=116.749/133.5600*133.5600
=116.749

Current CPI (Mar. 2026) = 133.5600.

Swedish Orphan Biovitrum AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 18.649 101.019 24.656
201609 19.086 101.138 25.205
201612 19.066 102.022 24.960
201703 19.872 102.022 26.015
201706 21.178 102.752 27.528
201709 22.544 103.279 29.154
201712 23.770 103.793 30.587
201803 25.595 103.962 32.882
201806 27.851 104.875 35.469
201809 30.079 105.679 38.015
201812 31.993 105.912 40.345
201903 47.032 105.886 59.324
201906 48.627 106.742 60.844
201909 50.946 107.214 63.465
201912 54.948 107.766 68.100
202003 60.543 106.563 75.881
202006 60.317 107.498 74.940
202009 60.841 107.635 75.495
202012 65.447 108.296 80.715
202103 67.578 108.360 83.294
202106 68.525 108.928 84.021
202109 70.367 110.338 85.176
202112 75.092 112.486 89.160
202203 76.882 114.825 89.426
202206 78.555 118.384 88.626
202209 80.886 122.296 88.336
202212 85.590 126.365 90.463
202303 89.613 127.042 94.211
202306 91.275 129.407 94.205
202309 101.441 130.224 104.040
202312 99.680 131.912 100.925
202403 105.591 132.205 106.673
202406 106.082 132.716 106.757
202409 108.008 132.304 109.033
202412 117.300 132.987 117.805
202503 113.636 132.825 114.265
202506 113.349 133.699 113.231
202509 104.385 133.480 104.448
202512 109.116 133.390 109.255
202603 116.749 133.560 116.749

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr74.74 mean?
Swedish Orphan Biovitrum AB (CHIX:SOBIS) has a Cyclically Adjusted Book per Share of kr74.74 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Swedish Orphan Biovitrum AB and its competitors.
Is Swedish Orphan Biovitrum AB's Cyclically Adjusted Book per Share too high?
Swedish Orphan Biovitrum AB's current Cyclically Adjusted Book per Share is kr74.74. Overall, Swedish Orphan Biovitrum AB has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Swedish Orphan Biovitrum AB's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Swedish Orphan Biovitrum AB's Cyclically Adjusted Book per Share of kr74.74 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Swedish Orphan Biovitrum AB and its competitors. Swedish Orphan Biovitrum AB's current Cyclically Adjusted Book per Share is kr74.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Swedish Orphan Biovitrum AB stock overvalued right now?
Based on GuruFocus' analysis, Swedish Orphan Biovitrum AB (CHIX:SOBIS) is currently considered Significantly Overvalued. The stock's GF Value™ is kr345.70, compared to a current price of kr463.20 — trading 34% above its estimated fair value. The current Cyclically Adjusted Book per Share is kr74.74. Swedish Orphan Biovitrum AB's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Swedish Orphan Biovitrum AB (CHIX:SOBIS), the current Cyclically Adjusted Book per Share is kr74.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Swedish Orphan Biovitrum AB (CHIX:SOBIS) Overvalued in 2026?

Based on GuruFocus' analysis, Swedish Orphan Biovitrum AB stock appears to be overvalued. The current stock price of kr463.20 is trading 34% above its estimated GF Value™ of kr345.70. GuruFocus considers Swedish Orphan Biovitrum AB to be Significantly Overvalued.

Key valuation signals for CHIX:SOBIS:

  • Cyclically Adjusted Book per Share: kr74.74
  • GF Value™: kr345.70 vs. price of kr463.20 (34% above fair value)
  • GF Score™: 85/100 with 6 warning signs

No single metric tells the full story. See the CHIX:SOBIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Swedish Orphan Biovitrum AB Business Description

Address Norra Stationsgatan 93A, Stockholm, SWE, SE-112 76
Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) in 2006 on long-acting hemophilia factor replacement programs. Biovitrum acquired Orfadin and a partnered product business with the acquisition of Swedish Orphan. Sobi launched hemophilia products Alprolix and Eloctate in Europe in 2016, and Altuvoct in 2024. Sobi has been building its immunology pipeline (rare-disease drug Gamifant, US rights to RSV antibodies Synagis and Beyfortus, gout drugs, complement drug Aspaveli) and a broader hematology pipeline (thrombocytopenia drug Doptelet, blood cancer drug Zynlonta, myelofibrosis drug Vonjo).
85GF Score

Get the complete analysis for CHIX:SOBIS

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr463.20
Price
kr345.70
GF Value